In Brief: FDA's Generic Drugs Advisory Committee
This article was originally published in The Tan Sheet
Executive Summary
FDA's Generic Drugs Advisory Committee: Will meet Sept. 6-7 to discuss the status of the Center for Drug Evaluation & Research's quality performance initiative in relation to formulation, dissolution and bioequivalence, as well as the advisory committee's relationship with CDER's new Office of Pharmaceutical Sciences. The meeting will be held at the Holiday Inn in Gaithersburg, Md, beginning at 8:30 a.m. on both days...